B7-H1/CD80 Interaction is Required for the Induction and Maintenance of Peripheral T-cell Tolerance
Overview
Authors
Affiliations
T-cell tolerance is the central program that prevents harmful immune responses against self-antigens, in which inhibitory PD-1 signal given by B7-H1 interaction plays an important role. Recent studies demonstrated that B7-H1 binds CD80 besides PD-1, and B7-H1/CD80 interaction also delivers inhibitory signals in T cells. However, a role of B7-H1/CD80 signals in regulation of T-cell tolerance has yet to be explored. We report here that attenuation of B7-H1/CD80 signals by treatment with anti-B7-H1 monoclonal antibody, which specifically blocks B7-H1/CD80 but not B7-H1/PD-1, enhanced T-cell expansion and prevented T-cell anergy induction. In addition, B7-H1/CD80 blockade restored Ag responsiveness in the previously anergized T cells. Experiments using B7-H1 or CD80-deficient T cells indicated that an inhibitory signal through CD80, but not B7-H1, on T cells is responsible in part for these effects. Consistently, CD80 expression was detected on anergic T cells and further up-regulated when they were re-exposed to the antigen (Ag). Finally, blockade of B7-H1/CD80 interaction prevented oral tolerance induction and restored T-cell responsiveness to Ag previously tolerized by oral administration. Taken together, our findings demonstrate that the B7-H1/CD80 pathway is a crucial regulator in the induction and maintenance of T-cell tolerance.
Kantheti U, Forward T, Lucas E, Schafer J, Tamburini P, Burchill M Sci Adv. 2025; 11(5):eadt3044.
PMID: 39879305 PMC: 11777207. DOI: 10.1126/sciadv.adt3044.
Mao Z, Hirdler J, Gicobi J, Maynes M, Hsu M, Dellacecca E bioRxiv. 2025; .
PMID: 39868106 PMC: 11761021. DOI: 10.1101/2025.01.18.631253.
Targeting HER2 in Gastroesophageal Cancer: A New Appetite for an Old Plight.
Cammarota A, Woodford R, Smyth E Drugs. 2025; 85(3):361-383.
PMID: 39843758 DOI: 10.1007/s40265-024-02132-2.
CAR-T cell therapy in Multiple Myeloma: current status and future challenges.
Swan D, Madduri D, Hocking J Blood Cancer J. 2024; 14(1):206.
PMID: 39592597 PMC: 11599389. DOI: 10.1038/s41408-024-01191-8.
Fighting Pancreatic Cancer with a Vaccine-Based Winning Combination: Hope or Reality?.
Brugiapaglia S, Spagnolo F, Intonti S, Novelli F, Curcio C Cells. 2024; 13(18.
PMID: 39329742 PMC: 11430323. DOI: 10.3390/cells13181558.